Adipokines as emerging mediators of immune response and inflammation

Nature Clinical Practice Rheumatology

Volumn 3, Issue 12, 2007, Pages 716-724

  Lago, Francisca ^a   Dieguez, Carlos ^b   Gómez Reino, Juan ^a   Gualillo, Oreste ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; CYTOKINE; HEPCIDIN; LEPTIN; OMENTIN; RESISTIN; UNCLASSIFIED DRUG; VASPIN; VISFATIN;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CLINICAL RESEARCH; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; EVIDENCE BASED MEDICINE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPONECTIN; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

EID: 36549042103     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0674     Document Type: Review

References (51)

1. Zhang Y et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432
2. Otero M et al. (2005) Leptin, from fat to inflammation: Old questions and new insights. FEBS Lett 579: 295-301
3. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919
4. Hotamisligil GS et al. (1993) Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259: 87-91
5. Tilg H et al. (2006) Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nature Rev Immunol 6: 772-783
6. Dayer JM et al. (2006) Adipose tissue has anti-inflammatory properties. Ann NY Acad Sci 1069: 444-453
7. Otero M et al. (2006) Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45: 944-950
8. Fruhbeck G (2006) Intracellular signalling pathways activated by leptin. Biochem J 393: 7-20
9. Gualillo O et al. (2002) Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2. Mol Cell Endocrinol 190: 83-89
10. Howard JK et al. (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104: 1051-1059
11. Matarese G et al. (2005) Leptin in immunology. J Immunol 174: 3137-3142
12. Faggioni R et al. (2001) Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15: 2565-2571
13. De Rosa et al. (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255
14. Otero M et al. (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65: 1198-1201
15. Toussirot E et al. (2007) The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14 1095-1100
16. + lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18 394-401
17. Bernotiene E et al. (2006). The role of leptin in innate and adaptive immune response. Arthritis Res Ther 8: 217-226
18. Gualillo O (2007) Further evidence for leptin involvement in cartilage homeostases. Osteoarthritis Cartilage 15: 857-860
19. Otero M et al. (2003) Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 48: 404-409
20. Otero M et al. (2005) Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: Synergistic effect of leptin with interleukin-1. Arthritis Res Ther 7: R581-R591
21. Simopoulou T et al. (2007) Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 15: 872-883
22. Iliopoulos D et al. (2007) Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: Possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis [doi:10.1136/ard.2007.069377]
23. Oh DK et al. (2007) Adiponectin in health and disease. Diabetes Obes Metab 9: 282-289
24. Kadowaki T et al. (2005) Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451
25. Matsuzawa Y (2006) Therapy Insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3: 35-42
26. Schaffler A et al. (2003) Adipocytokines in synovial fluid. JAMA 290: 1709-1710
27. Sada KE et al. (2006) Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33: 1545-1552
28. Ehling A et al. (2006) The potential of adiponectin in driving arthritis. J Immunol 176: 4468-4478
29. Lago R et al. (2007) Adiponectin induces nitric oxide synthase type 2 and pro-inflammatory cytokines in chondrocytes. Ann Rheum Dis 66(Suppl 11): 142
30. Steppan CM et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307-312
31. Harsch IA et al. (2004) Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation? Med Sci Monit 10: CR510-CR515
32. Reilly MP et al. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939
33. Lehrke M et al. (2004) An inflammatory cascade leading to hyperresistinernia in humans. PLoS Med 1: E45
34. Bokarewa M et al. (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 5789-5795
35. Senolt L et al. (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66: 458-463
36. Fukuhara A et al. (2005) Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430
37. Jia SH et al. (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113: 1318-1327
38. Moschen AR et al. (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178 1748-1758
39. Tatemoto K et al. (1998) Isolation and characterization of a novel enclogenous pepticle ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471-476
40. Daviaud D et al. (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20: 1528-1530
41. Xu H et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830
42. Hicla K et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102: 10610-10615
43. Park CH et al. (2001) Hepcidin, a urinary antimicrobial pepticle synthesized in the liver. J Biol Chem 276: 7806-7810
44. Bekri S et al. (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131: 788-796
45. Fleming RE (2007) Hepcidin activation during inflammation: Make it STAT. Gastroenterology 132: 447-449
46. Pietrangelo A et al. (2007) STAT3 is required for IL-6-gpl 30-dependent activation of hepcidin in vivo. Gastroenterology 132: 294-300
47. Schaffler A et al. (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 1732: 96-102
48. Gerwick L et al. (2007) Gene transcript changes in individual rainbow trout livers following an inflammatory stimulus. Fish Shellfish Immunol 22: 157-171
49. de Souza Batista CM et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56: 1655-1661
50. Kuperman DA et al. (2005) Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 116: 305-311
51. Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4: 341-348